Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 19, 2002BMJOpen Access

Efficacy and safety of COX 2 inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

RJRoger JonesRoyal Marsden NHS Foundation Trust

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Roger Jones (2002) studied this question.

synapsesocial.com/papers/6a75fd4cb59e1a4df678675bhttps://doi.org/10.1136/bmj.325.7365.607
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1COX‐2, prostanoids and colon cancer2002 · 36 citations
  2. 2Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs2002 · 270 citations
  3. 3Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis2000 · 3,171 citations
  4. 4Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis2000 · 4,051 citations
  5. 5Nsaid Inhibition of Gi Cancer Growth: Clinical Implications and Molecular Mechanisms of Action2002 · 127 citations